       
       Guidance for Industry 
                           
        Safety Labeling Changes â€”
              Implementation of  
              Section 505(o)(4) of  
                 the FD&C Act  
                           
       
       
                           
                           
                           
                           
                           
                           
                           
                           
                           
                           
                           
                           
                U.S. Department of Health and Human Services 
                   Food and Drug Administration 
               Center for Drug Evaluation and Research (CDER) 
              Center for Biologics Evaluation and Research (CBER) 
                           
                        July 2013 
                       Drug Safety 
                           
                           
                   OMB Control Number 0910-0734 
                    Expiration Date:  03/31/2016 
                (Expiration date will be updated periodically.) 
             See additional PRA statement in section VII of this guidance. 
       
